Ocular Therapeutix (OCUL)
6.61
+0.13 (2.01%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
October 20, 2026 6:53 AM - StreetInsider
Form 8-K OCULAR THERAPEUTIX, INC For: Oct 14
October 16, 2026 4:15 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Oct 08 Filed by: Anderman Todd
October 13, 2026 5:01 PM - SEC Filing
UBS Starts Ocular Therapeutix (OCUL) at Buy
October 12, 2026 2:20 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 9, 2026 7:00 AM - Globe NewsWire
Form 144 OCULAR THERAPEUTIX, INC Filed by: Anderman Todd
October 8, 2026 4:28 PM - SEC Filing
Top 4 Healthcare Stocks Backed by Raymond James Analysts
October 8, 2026 9:53 AM - StreetInsider
Form 4 OCULAR THERAPEUTIX, INC For: Oct 02 Filed by: Kaiser Peter
October 6, 2026 4:44 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Oct 02 Filed by: Heier Jeffrey S.
October 6, 2026 4:44 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter
October 2, 2026 4:08 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S.
October 2, 2026 4:06 PM - SEC Filing
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences
October 1, 2026 7:00 AM - Globe NewsWire
RBC Capital on Ocular Therapeutix (OCUL): 'Sell-Off Overdone'
September 29, 2026 9:29 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2026 7:00 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
September 16, 2026 6:57 AM - StreetInsider
Ocular Therapeutix completes pre-NDA meeting with FDA for wet AMD drug
September 15, 2026 7:01 AM - StreetInsider
Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD
September 15, 2026 7:00 AM - Globe NewsWire
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Kaiser Peter
August 26, 2026 6:00 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Nayak Sanjay
August 26, 2026 5:58 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Heier Jeffrey S.
August 26, 2026 5:57 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Dugel Pravin
August 26, 2026 5:56 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Nayak Sanjay
August 24, 2026 4:46 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin
August 24, 2026 4:45 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S.
August 24, 2026 4:44 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter
August 24, 2026 4:43 PM - SEC Filing
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 13, 2026 4:05 PM - Globe NewsWire
Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL
August 12, 2026 10:09 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:05 PM - Globe NewsWire
Form S-8 OCULAR THERAPEUTIX, INC
August 3, 2026 7:59 AM - SEC Filing
Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c
August 3, 2026 7:19 AM - StreetInsider
Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30
August 3, 2026 7:17 AM - SEC Filing
Form 8-K OCULAR THERAPEUTIX, INC For: Aug 03
August 3, 2026 7:08 AM - SEC Filing
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
August 3, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A OCULAR THERAPEUTIX, INC Filed by: BlackRock, Inc.
July 29, 2026 3:21 PM - SEC Filing
Full Article List
